Detalhe da pesquisa
1.
EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma.
Int J Cancer
; 143(5): 1188-1201, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29582409
2.
Combination of protein and cell internalization SELEX identifies a potential RNA therapeutic and delivery platform to treat EphA2-expressing tumors.
Mol Ther Nucleic Acids
; 32: 758-772, 2023 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37251690
3.
uPA deficiency exacerbates muscular dystrophy in MDX mice.
J Cell Biol
; 178(6): 1039-51, 2007 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-17785520
4.
α-Enolase, a multifunctional protein: its role on pathophysiological situations.
J Biomed Biotechnol
; 2012: 156795, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23118496
5.
Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1.
Oncogene
; 41(18): 2638-2650, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35354905
6.
Metastasis Assessment in Ewing Sarcoma Using Orthotopic Xenografts.
Methods Mol Biol
; 2226: 201-213, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33326104
7.
Harnessing subcellular-resolved organ distribution of cationic copolymer-functionalized fluorescent nanodiamonds for optimal delivery of active siRNA to a xenografted tumor in mice.
Nanoscale
; 13(20): 9280-9292, 2021 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33982741
8.
LOXL2 promotes oncogenic progression in alveolar rhabdomyosarcoma independently of its catalytic activity.
Cancer Lett
; 474: 1-14, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31911079
9.
Bcl-xL inhibition enhances Dinaciclib-induced cell death in soft-tissue sarcomas.
Sci Rep
; 9(1): 3816, 2019 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30846724
10.
DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1.
Cancer Lett
; 386: 196-207, 2017 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27894957
11.
Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway.
Oncotarget
; 7(35): 56889-56903, 2016 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-27487136
12.
Alpha-enolase plasminogen receptor in myogenesis.
Front Biosci
; 10: 30-6, 2005 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15574344
13.
The plasminogen activation system in skeletal muscle regeneration: antagonistic roles of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1).
Front Biosci
; 10: 2978-85, 2005 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15970552
14.
"(Not) all (dead) things share the same breath": identification of cell death mechanisms in anticancer therapy.
Cancer Res
; 75(6): 913-7, 2015 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25724677
15.
The importance of being dead: cell death mechanisms assessment in anti-sarcoma therapy.
Front Oncol
; 5: 82, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25905041
16.
Plasmin generation dependent on alpha-enolase-type plasminogen receptor is required for myogenesis.
Thromb Haemost
; 90(4): 724-33, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14515195
17.
Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth.
Oncotarget
; 5(20): 9744-55, 2014 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25313138
18.
Requirement of plasminogen binding to its cell-surface receptor α-enolase for efficient regeneration of normal and dystrophic skeletal muscle.
PLoS One
; 7(12): e50477, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23239981
19.
Cell Death Identification in Anticancer Therapy-Response.
Cancer Res
; 75(17): 3682, 2015 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26286475
20.
Plasminogen activator inhibitor type-1 inhibits insulin signaling by competing with alphavbeta3 integrin for vitronectin binding.
Eur J Biochem
; 270(5): 814-21, 2003 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-12603314